The Newsweek rankings employ a multifaceted analytical framework designed to assess hospital performance in quantitative and qualitative dimensions, including clinical outcomes, patient experience, innovation, and reputation. These elements are weighted across four critical pillars: objective quality metrics, nationwide reputation surveys, patient-reported experience measures, and patient-reported outcome measures (PROMs) implementation. Hospitals achieving distinction within this framework demonstrate robust clinical system integration, advanced procedural capabilities, and progressive patient-centered care models. Ochsner Health hospitals successfully navigated these rigorous criteria, validating their operational and clinical process excellence on a state and national scale.

Ochsner Health’s portfolio includes a diverse set of care facilities spread across Louisiana and Mississippi, with a network that extends to encompass a wide range of specialties and subspecialties. The honored institutions represent a cross-section of this network, each reflecting tailored approaches to meet specific community health needs while maintaining consistent standards of care. These hospitals operate with enhanced technological infrastructures and interdisciplinary clinical teams, enabling them to not only meet but often exceed benchmarks established for procedural safety, patient satisfaction, and innovative treatment outcomes. Such distinctions are critical in enhancing community trust and healthcare accessibility.

Central to Ochsner Health’s philosophy is the integration of evidence-based medicine with patient-centric care approaches, which seek to optimize both clinical results and patient quality of life. This integration is manifested in comprehensive care pathways, including preoperative assessments, streamlined inpatient protocols, and post-discharge continuity programs supported by digital health tools. The implementation of these care pathways aligns intimately with the evaluative measures used by Newsweek and Statista, particularly those emphasizing patient-reported outcomes, which provide crucial feedback on treatment effectiveness and patient well-being beyond conventional clinical parameters.

The recognition also underscores the pivotal role of Ochsner Health’s clinical teams, whose clinical expertise and dedication significantly impact patient journey outcomes. Frontline healthcare providers and support staff at the recognized hospitals engage in continuous education and quality improvement initiatives, fostering an environment of clinical vigilance and responsiveness. This cultural framework enhances the capacity for early detection of complications, personalized therapeutic adjustments, and integrative multidisciplinary collaborations that collectively elevate care quality.

Innovation emerges as a key driver within the organizational strategy of Ochsner Health, illustrated by the adoption of cutting-edge technologies and clinical research participation. Advanced diagnostic modalities, such as high-resolution imaging and genomic sequencing, inform precision medicine strategies that tailor treatments to individual patient profiles. Additionally, Ochsner’s investment in digital health platforms enables enhanced patient engagement and remote monitoring, facilitating proactive management of chronic conditions and reducing hospital readmissions. This commitment to technological advancement plays a critical role in maintaining the hospitals’ competitive edge and aligns with the innovation criteria used in the hospital ranking process.

Patient experience, measured through comprehensive surveys and real-time feedback mechanisms, forms a cornerstone of the evaluation for America’s Best-in-State Hospitals. Ochsner Health’s hospitals have invested substantially in patient experience initiatives, including expanded patient navigation services, culturally competent care programs, and enhanced communication protocols. These initiatives contribute to overall patient satisfaction and trust, elements that not only influence ranking outcomes but also improve adherence to treatment plans and health outcomes. The integration of such patient-centered measures illustrates the holistic approach these hospitals take beyond mere clinical performance metrics.

The hospitals recognized this year by Newsweek from the Ochsner network include Leonard J. Chabert Medical Center in Houma, Ochsner Lafayette General Medical Center in Lafayette, Ochsner Medical Center in Baton Rouge, Ochsner Medical Center in Kenner, and Ochsner Rush Medical Center in Meridian. Each facility serves distinctive demographic and epidemiological profiles, necessitating adaptive strategies to address localized health challenges while delivering uniformly high standards of care. Their inclusion in this prestigious list speaks to not only their individual accomplishments but also to the strength of the integrated health system that supports them.

Ochsner Health’s recognition among the country’s best hospitals provides a model for other healthcare organizations aiming to harmonize clinical excellence with compassionate, innovative patient care. Achieving distinction in a dataset encompassing over 6,000 hospitals nationwide affirms the organization’s successful approaches in tackling complex health system challenges, from resource allocation to care delivery optimization. This distinction could serve as a catalyst for further innovation, investment, and policy development aimed at enhancing health outcomes in the Gulf South and beyond.

The evaluation methods used by Newsweek and Statista represent some of the most comprehensive assessments of hospital performance currently available. By incorporating patient-reported outcome measures alongside traditional clinical metrics, the ranking process captures the real-world effectiveness of hospital care and its impact on patient health and quality of life. Ochsner Health’s performance within this framework reflects their ability to integrate advanced clinical protocols with patient-centered services, highlighting the growing importance of such holistic evaluation models in healthcare accreditation and reputation management.

Understanding the dynamics that enable certain hospitals to excel requires a deep dive into organizational culture, clinical leadership, and operational excellence, all areas where Ochsner Health has invested strategically. Leadership’s focus on interdisciplinary collaboration, continuous quality improvement, and adaptive learning environments fosters resilience and responsiveness to evolving health challenges. This emphasis enhances the predictive capacity of hospitals to manage complications, innovate care pathways, and maintain exemplary patient safety records.

Looking forward, the recognition garnered by these Ochsner Health hospitals positions them as benchmarks for the healthcare industry, particularly in regions with similar demographic and epidemiological profiles. Their success highlights the critical importance of integrated data analytics, patient engagement technologies, and a commitment to continuous professional development in achieving and sustaining healthcare excellence. As healthcare systems navigate the complexities of technological transformation and rising patient expectations, Ochsner’s model offers valuable insights into effective strategies for harmonizing clinical performance with patient experience and innovation.

In summary, the 2026 Newsweek America’s Best-in-State Hospitals list affirms Ochsner Health’s role as a leader in delivering superior healthcare within the Gulf South. The recognition reflects a multifaceted commitment to clinical excellence, patient-centered care, operational innovation, and community health responsiveness. It serves as a testament to the tireless efforts of healthcare providers, administrators, and support staff dedicated to advancing health outcomes and fostering resilience within their communities through the delivery of transformative healthcare services.

Subject of Research: Healthcare quality and innovation recognition in regional hospital systems

Article Title: Ochsner Health Hospitals Named Among America’s Best-in-State for Clinical Excellence and Innovation

News Publication Date: 2024

Web References:

• Newsweek America’s Best-in-State Hospitals 2026
• Ochsner Health Official Site

Keywords: Healthcare quality, Clinical excellence, Patient experience, Innovation in healthcare, Hospital rankings, Patient-reported outcome measures, Ochsner Health, Gulf South healthcare

Keck Hospital of USC, the flagship acute care hospital with 343 beds, caters to a wide spectrum of complex health needs, providing specialized medical and surgical services with a focus on advancing patient safety through innovation and adherence to stringent protocols. Meanwhile, USC Verdugo Hills Hospital, a more localized community hospital with 140 beds, serves the populations of Glendale, La Cañada Flintridge, and the Foothill communities, emphasizing community-centered care and patient safety. The dual recognition of both hospitals underscores the comprehensive and robust safety culture permeating Keck Medicine of USC.

The rigorous grading methodology employed by The Leapfrog Group integrates numerous metrics that include prevention of medical errors, reduction of hospital-acquired infections, surgical complications, and the successful implementation of evidence-based safety protocols. These criteria are continuously refined in line with evolving medical standards to ensure hospitals maintain the utmost levels of patient safety. The distinction earned by Keck Hospital marks the eleventh time since 2019 that it has received an “A” for safety, highlighting a consistent trajectory of excellence and improvements despite increasingly stringent evaluation criteria.

The ongoing refinement of safety criteria represents a significant challenge for healthcare providers. It demands a proactive approach involving multidisciplinary collaboration, integration of emerging data analytics, and relentless quality assurance mechanisms. Stephanie Hall, MD, the chief medical officer at Keck Medical Center of USC, emphasizes the institution’s commitment to evolving safety protocols and healthcare delivery methods that consistently reduce risks associated with hospitalization. The hospital’s use of advanced electronic health record monitoring systems and real-time infection control technologies exemplifies this commitment.

Furthermore, at USC Verdugo Hills Hospital, patient safety initiatives have been deeply embedded into clinical workflows. The implementation of comprehensive education programs for clinical staff alongside real-time monitoring of patient vitals and outcomes has fostered a culture whereby patient safety is the paramount priority. CEO Armand Dorian, MD, MMM, articulates that this achievement reflects the collective effort of every healthcare provider acting with mindfulness towards safety challenges unique to community hospitals, such as resource allocation and local disease epidemiology.

The Leapfrog Group’s hospital grading system is transparent and publicly accessible, providing patients and their families with a reliable, science-based assessment tool when making informed healthcare decisions. Grading occurs biannually, in the fall and spring, ensuring that hospitals are continuously motivated to enhance their safety protocols in response to the most recent clinical evidence and technological advances. This dynamic grading mechanism also serves to benchmark hospitals against national safety standards, fostering an environment of accountability and sustained improvement across healthcare systems.

Keck Medicine’s consistent attainment of national quality honors—beyond Leapfrog grades—further cements its role as a leader in healthcare innovation and patient-centered care. For instance, Keck Hospital’s recognition as a top performer by Vizient, Inc. for 2025 situates it among the top twelve hospitals nationwide that excel in delivering high-quality care. This distinction is grounded in objective data evaluating clinical efficiency, outcomes, and patient satisfaction, reinforcing the hospital’s pioneering role in translating complex science into compassionate patient care.

Hospital executives accentuate the importance of fostering a culture that marries clinical expertise with systemic safety initiatives. Marty Sargeant, MBA, CEO of Keck Medical Center, highlights how the relentless efforts of faculty and staff materialize daily in consistent safety outcomes and elevated quality of care. This synergy between personnel dedication and institutional support elucidates a replicable blueprint for other health systems striving for comparable safety benchmarks.

At the core of these accomplishments lies an intricate network of quality assurance measures involving data collection, infection prevention protocols, multidisciplinary care teams, and patient engagement strategies. Both hospitals make use of state-of-the-art analytics platforms that integrate patient safety indicators to predict and prevent adverse events. They also leverage clinical decision support systems embedded within electronic health records to provide real-time guidance to care providers, enhancing clinical judgment and reducing errors effectively.

The hospitals’ performance not only reflects their internal capacities but also signals broader shifts in healthcare delivery paradigms—towards value-based care models where safety, quality, and patient outcomes are intricately linked. These models encourage investment in continuous education, technology-driven monitoring, and a systems approach to addressing complex safety challenges. Keck Medicine’s milestones in this context position it as a vital contributor to the national dialogue on healthcare safety innovation.

Patients and their families can access detailed grading information and gain insights into hospital safety protocols through HospitalSafetyGrade.org, a public platform designed to empower healthcare consumers. The availability of these resources promotes transparency and public engagement, further enhancing institutional accountability. This openness is vital for encouraging systemic improvements across hospital networks nationwide, fostering trust and disseminating best practices.

In summary, the Fall 2025 Leapfrog Group “A” ratings for both Keck Hospital of USC and USC Verdugo Hills Hospital represent a significant achievement that reflects an unwavering dedication to elevating patient safety standards. Through the integration of cutting-edge safety protocols, data analytics, and a culture of continuous improvement, these hospitals exemplify how healthcare institutions can mitigate risks and enhance patient outcomes. Their success story serves as both inspiration and blueprint for hospitals across the country striving to meet and exceed evolving safety expectations.

Subject of Research:
Article Title:
News Publication Date:
Web References: https://www.hospitalsafetygrade.org/, https://www.keckmedicine.org/
References:
Image Credits:
Keywords: Hospitals, Health care delivery, Patient safety, Hospital safety grade, Medical facilities, Healthcare quality, Patient outcomes, Infection prevention, Healthcare innovation, Value-based care

Historically, the role of pharmacists has been predominantly focused on medication dispensation and patient counseling. However, as healthcare systems grapple with increasing demands, the necessity for expanding the roles of healthcare professionals has become apparent. Pharmacist prescribing, particularly in specialized areas like dermatology, presents a unique opportunity to leverage the expertise of pharmacists while alleviating some burden on traditionally prescriptive professions. This study scrutinizes the implementation aspects of such a service, establishing a framework for evaluating its effectiveness, safety, and acceptance among both healthcare providers and patients.

Dermatological conditions often present complex clinical challenges, ranging from acne and eczema to psoriasis and skin cancers. Managing these conditions typically involves a multitude of medications and treatment regimens that can be cumbersome for patients to navigate. A pharmacist prescribing service could bridge gaps in treatment access and continuity, offering patients quicker routes to necessary therapies and potentially reducing the waiting times often associated with dermatology appointments. This service could significantly enhance patient satisfaction and compliance by facilitating immediate access to care.

Moreover, the study’s protocol carries significant implications for interprofessional collaboration within healthcare teams. By outlining a systematic approach to pharmacist-led prescribing, it encourages a more integrated model of care where pharmacists and physicians work synergistically. This model aims to optimize patient management while ensuring that pharmacists operate within their full scope of practice. The collaborative aspect is crucial, as it promotes shared responsibility and accountability in patient care, which could lead to better health outcomes and a more cohesive healthcare experience for patients.

Central to the study is the evaluation component, which systematically assesses various dimensions following the implementation of the pharmacist prescribing service. Metrics such as patient outcomes, satisfaction levels, and the efficacy of treatment regimens will be closely monitored. This data is invaluable, as it can provide insights into the strengths and limitations of the prescribing model. Gaining a clear understanding of these factors will help refine the service to better meet patient needs and improve overall treatment approaches.

Training and education form another pivotal element of this study protocol. For pharmacists to effectively undertake prescribing responsibilities, they must be equipped with the necessary knowledge and skills pertinent to dermatology. Education programs designed to enhance pharmacists’ understanding of dermatological conditions, treatment options, and patient communication will be essential. The study indicates a commitment to building a robust educational framework that prepares pharmacists to confidently manage complex skin conditions and engage positively with patients.

In addition to the educational aspects, the implementation protocol highlights the importance of safety and risk management in the prescribing process. With the ability to prescribe medications comes the responsibility to practice safely and ethically. The study places a strong emphasis on risk assessment measures, ensuring that pharmacists can identify potential side effects, contraindications, and interactions associated with dermatological treatments. This meticulous attention to safety helps to instill confidence in both healthcare providers and patients regarding pharmacist-led prescribing.

Concerns surrounding the acceptance of such services play a significant role in the anticipated outcomes of this implementation study. The research design includes qualitative assessments to gauge perceptions from both patients and healthcare providers regarding the pharmacist prescribing model. Understanding these perceptions is vital to addressing possible hesitations and fostering a culture that embraces the expanded role of pharmacists in patient care.

Furthermore, economic implications of pharmacist prescribing are considered in the study. By potentially reducing the number of referrals to dermatologists, the service could lead to cost savings within the healthcare system. Assessing the financial viability of this initiative will be a critical component of the evaluation, as demonstrating a positive return on investment could bolster support for similar initiatives in rural and underserved areas where healthcare resources are limited.

As the study protocol unfolds, a broader conversation about the future of pharmacist roles in healthcare is anticipated. With increasing evidence supporting such innovative models, other healthcare sectors may begin to explore similar approaches. The positive outcomes from the dermatological prescribing initiative could serve as a blueprint for future expansions into other areas where pharmacists can make a significant impact on patient care.

In conclusion, the implementation evaluation of a pharmacist prescribing service for dermatological conditions marks a significant stride towards optimizing healthcare delivery. By empowering pharmacists, enhancing interprofessional collaboration, ensuring patient safety, and undergoing rigorous evaluation, this protocol not only aims to improve dermatological care but also sets a precedent for the evolving role of pharmacists in patient management across various medical disciplines.

Emerging from this study is the promise of a more integrated healthcare system, where pharmacists, equipped with the right expertise and authority, actively contribute to patient outcomes. This initiative reflects a broader trend towards recognizing the essential role that pharmacists can play in addressing complex healthcare challenges and improving access to effective treatment options. As the landscape of healthcare continues to shift, the outcomes of this study could very well prove to be a catalyst for substantial change in prescribing practices and patient care models worldwide.

Subject of Research: Implementation evaluation of a pharmacist prescribing service for the management of dermatological conditions.

Article Title: Implementation evaluation of a pharmacist prescribing service for the management of dermatological conditions: a study protocol.

Article References:
Amador-Fernandez, N., Benrimoj, S.I., Martinez-Mardones, F. et al. Implementation evaluation of a pharmacist prescribing service for the management of dermatological conditions: a study protocol. BMC Health Serv Res 25, 1333 (2025). https://doi.org/10.1186/s12913-025-13128-3

Image Credits: AI Generated

DOI:

Keywords: Pharmacist prescribing, dermatology, healthcare innovation, patient access, interprofessional collaboration.